Henry Schein, Inc. (HSIC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HSIC Revenue Growth
Revenue Breakdown (FY 2018)
HSIC's revenue distribution by segment and geography for fiscal year 2018
By Product/Segment
By Geography
HSIC Revenue Analysis (2014–2025)
As of May 8, 2026, Henry Schein, Inc. (HSIC) generated trailing twelve-month (TTM) revenue of $13.18 billion, reflecting solid growth of +7.7% year-over-year. The most recent quarter (Q4 2025) recorded $3.44 billion in revenue, up 2.9% sequentially.
Looking at the longer-term picture, HSIC's 5-year compound annual growth rate (CAGR) stands at +5.4%, indicating steady revenue expansion. The company achieved its highest annual revenue of $13.20 billion in 2018.
Revenue diversification analysis shows HSIC's business is primarily driven by Healthcare Distribution (96%), and Technology (4%). With over half of revenue concentrated in Healthcare Distribution, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including DXPE (+11.9% YoY), OMI (-41.0% YoY), and MCK (+12.4% YoY), HSIC has underperformed the peer group in terms of revenue growth. Compare HSIC vs DXPE →
HSIC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HSICCurrent | $13.2B | +7.7% | +5.4% | 5.7% | |
 DXPE | $2.0B | +11.9% | +14.9% | 8.8% | |
 OMI | $2.8B | -41.0% | -20.1% | 1.0% | |
 MCK | $359.1B | +12.4% | +9.2% | 1.2% | |
 CAH | $222.6B | +12.8% | +7.8% | 1.0% | |
 XRAY | $3.7B | -1.0% | +2.0% | 6.8% |
HSIC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $13.18B | +4.0% | $3.84B | 29.1% | $758.0M | 5.7% |
| 2024 | $12.67B | +2.7% | $3.77B | 29.7% | $729.0M | 5.8% |
| 2023 | $12.34B | -2.4% | $3.65B | 29.6% | $714.0M | 5.8% |
| 2022 | $12.65B | +2.0% | $3.65B | 28.9% | $938.0M | 7.4% |
| 2021 | $12.40B | +22.5% | $3.67B | 29.6% | $854.8M | 6.9% |
| 2020 | $10.12B | +1.3% | $2.81B | 27.8% | $567.4M | 5.6% |
| 2019 | $9.99B | -24.4% | $3.09B | 31.0% | $733.0M | 7.3% |
| 2018 | $13.20B | +5.9% | $2.91B | 22.0% | $693.5M | 5.3% |
| 2017 | $12.46B | +7.7% | $3.40B | 27.3% | $864.7M | 6.9% |
| 2016 | $11.57B | +8.9% | $3.23B | 27.9% | $817.5M | 7.1% |
See HSIC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HSIC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HSIC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHSIC — Frequently Asked Questions
Quick answers to the most common questions about buying HSIC stock.
Is HSIC's revenue growth accelerating or slowing?
HSIC maintains +7.7% revenue growth, in line with its 5-year CAGR of +5.4%. TTM revenue stands at $13.2B. Growth rate remains consistent with historical average.
What is HSIC's long-term revenue growth rate?
Henry Schein, Inc.'s 5-year revenue CAGR of +5.4% reflects the sustained expansion pattern. Current YoY growth of +7.7% is near this long-term average.
How is HSIC's revenue distributed by segment?
HSIC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.